查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363332

CRRT（連續腎臟替代療法）市場規模、佔有率、趨勢分析報告：按產品、按方式、按地區、細分趨勢，2023-2030

Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

CRRT（連續性腎臟替代療法）市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球 CRRT（連續性腎臟替代治療）市場規模預計將達到 26.038 億美元。

預計2023年至2030年該市場將以8.6%的年複合成長率擴張。市場成長的主要促進因素是充血性心臟衰竭和急性腎衰竭的患病不斷增加。由於急性患病盛行率增加，預計 COVID-19 將對市場產生積極影響。據世界衛生組織稱，急性腎損傷是一種可能危及生命的疾病，其中腎臟停止功能，尿毒症和液體毒素在體內積聚，是 COVID-19 的眾多副作用之一。因此，隨著 COVID-19 疫情的蔓延，對 CRRT 的需求可能會持續上升。

預計技術進步將成為預測期內市場成長的關鍵驅動力。例如，2020年8月，全球急診護理領域的領導者百特國際公司（Baxter International）其用於體外循環局部檸檬酸鹽抗凝的含有Regiocit檸檬酸鹽的替換溶液獲得美國食品藥物管理局（ FDA）的批准，並宣布已收到緊急通知使用授權 (EUA)。根據 EUA 的規定，Regiosit 專門用於在 COVID-19核准流行期間接受 CRRT（連續腎臟替代治療）且需要局部檸檬酸鹽抗凝血的成年患者的替代液。

CRRT（持續性腎臟替代療法）市場報告亮點

  • 以按產品來看，消耗品板塊的銷售佔有率最大，2022年將達到60.6%。與其他細分市場相比，消耗品市場是最大的，因為這些產品價格低廉，但可以重複購買和使用。
  • 按方式分，連續靜脈血液濾過（CVVH）領域在 2022 年佔據最大的銷售佔有率，為 31.6%。重症監護病房急性腎損傷患者中常見的液體超負荷情況預計會增加，從而推動 CVVH 市場的成長。
  • CRRT（持續性腎臟替代治療）市場是亞太地區成長最快的市場，成長率為9.8%。該地區的成長受到多種要素的推動，包括技術進步、醫療基礎設施的發展以及龐大的患者基礎。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 CRRT（持續性腎臟替代治療）市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • CRRT（持續性腎臟替代療法）市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 CRRT（持續性腎臟替代療法）市場：按產品估計和趨勢分析

  • CRRT（連續腎臟替代治療）市場：重點
  • CRRT（持續性腎臟替代療法）市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 系統
  • 消耗品

第5章 CRRT（持續性腎臟替代治療）市場：依模式估計與趨勢分析

  • CRRT（連續腎臟替代治療）市場：重點
  • CRRT（持續性腎臟替代療法）市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 慢速超過濾(SCUF)
  • 連續性靜脈靜脈血液濾過（CVVH）
  • 連續性靜脈-靜脈血液透析機（CVVHD）
  • 連續性靜脈-靜脈血液透析機（CVVHDF）

第6章 CRRT（持續性腎臟替代治療）市場：區域估計與趨勢分析

  • 區域展望
  • CRRT（連續腎臟替代治療）市場（按地區）：重點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要參與企業的最新發展和影響分析
  • 市場參與企業分類
    • B. BRAUN MELSUNGEN AG
    • BAXTER INTERNATIONAL, INC.
    • FRESENIUS MEDICAL CARE AG & CO. KGAA
    • ASAHI KASEI CORPORATION
    • NIPRO CORPORATION
    • TORAY MEDICAL CO., LTD.
    • NXSTAGE MEDICAL, INC
    • MEDTRONIC PLC
Product Code: GVR-1-68038-607-3

Continuous Renal Replacement Therapy Market Growth & Trends:

The global continuous renal replacement therapy market size is anticipated to reach USD 2,603.8 million by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 8.6% from 2023 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure. The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.

Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Continuous Renal Replacement Therapy Market Report Highlights:

  • By product, the consumables segment held the largest revenue share of 60.6% in 2022. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments
  • Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.6% in 2022. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth
  • Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.8%. Various factors are responsible for the region growth such as technological advancement, growing healthcare infrastructure development as well as and presence of such a huge patient base in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Modality
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous Renal Replacement Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Continuous Renal Replacement Therapy Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Continuous Renal Replacement Therapy Market: Key Takeaways
  • 4.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. System
    • 4.3.1. System market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Continuous Renal Replacement Therapy Market: Modality Class Estimates & Trend Analysis

  • 5.1. Continuous Renal Replacement Therapy Market: Key Takeaways
  • 5.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Slow Continuous Ultra-Filtration (SCUF)
    • 5.3.1. Slow continuous ultra-filtration market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Continuous Venovenous Hemofiltration (CVVH)
    • 5.4.1. Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.5.1. Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Continuous Venovenous Hemodiafiltration (CVVHDF)
    • 5.6.1. Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Continuous Renal Replacement Therapy Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. U.K.
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. B. BRAUN MELSUNGEN AG
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. BAXTER INTERNATIONAL, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. FRESENIUS MEDICAL CARE AG & CO. KGAA
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. ASAHI KASEI CORPORATION
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. NIPRO CORPORATION
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. TORAY MEDICAL CO., LTD.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. NXSTAGE MEDICAL, INC
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. MEDTRONIC PLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 7 Canada continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 9 Europe continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 14 UK continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 16 France continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 17 France continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 18 Italy continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 20 Spain continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 22 Sweden continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 24 Norway continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 26 Denmark continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 33 China continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 China continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 35 India continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 36 India continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 37 Australia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 39 Thailand continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 41 South Korea continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 43 Latin America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 48 Mexico continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 50 Argentina continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 59 UAE continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 61 Kuwait continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Continuous renal replacement therapy: market outlook
  • Fig. 9 Continuous renal replacement therapy competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Continuous renal replacement therapy market driver impact
  • Fig. 15 Continuous renal replacement therapy market restraint impact
  • Fig. 16 Continuous renal replacement therapy market strategic initiatives analysis
  • Fig. 17 Continuous renal replacement therapy market: Product movement analysis
  • Fig. 18 Continuous renal replacement therapy market: Product outlook and key takeaways
  • Fig. 19 System market estimates and forecasts, 2018 - 2030
  • Fig. 20 Consumables market estimates and forecasts, 2018 - 2030
  • Fig. 21 Continuous renal replacement therapy market: Modality class outlook movement analysis
  • Fig. 22 Continuous renal replacement therapy market: Modality class outlook and key takeaways
  • Fig. 23 Slow continuous ultra-filtration market (SCUF) estimates and forecasts, 2018 - 2030
  • Fig. 24 Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 - 2030
  • Fig. 25 Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 - 2030
  • Fig. 26 Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 - 2030
  • Fig. 27 Continuous renal replacement therapy market: Regional movement analysis
  • Fig. 28 Continuous renal replacement therapy market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030